Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Thalidomide

Thalidomide

pharmaceutical raw materials
Thalidomide structure

Thalidomide 

structure
  • CAS No:

    50-35-1

  • Formula:

    C13H10N2O4

  • Chemical Name:

    Thalidomide

  • Synonyms:

    1H-Isoindole-1,3(2H)-dione,2-(2,6-dioxo-3-piperidinyl)-;Phthalimide,N-(2,6-dioxo-3-piperidyl)-;2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;K 17;Contergan;N-(2,6-Dioxo-3-piperidyl)phthalimide;Distaval;Kevadon;α-Phthalimidoglutarimide;α-(N-Phthalimido)glutarimide;3-Phthalimidoglutarimide;N-Phthaloylglutamimide;α-N-Phthalylglutaramide;Softenon;Thalidomide;Sedoval;Softenil;Quetimid;Talimol;(±)-Thalidomide;1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline;Thalomid;Celgene;Suaramide;Talinol;Neurosedyn;NSC 66847;Sedalis;Pantosediv;NSC 527179;Myrin;Sauramide;Pharmion;Thaled;Synovir;N-(2,6-Dioxo-3-piperidinyl)phthalimide;Immunoprin;2-(2,6-Dioxopiperidin-3-yl)isoindoline-1,3-dione;2-(2,6-Dioxopiperidin-3-yl)isoindole-1,3-dione;2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione;2-(2,6-Dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione;731-40-8;14088-68-7

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

Thalidomide is initially promoted as a sedative, inhibits ereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties.

Thalidomide Basic Attributes

258.23

258.23

200-031-1

2925190090

Characteristics

83.6

0.3

white

1.5±0.1 g/cm3

270 °C

509.7°C at 760 mmHg

262.1±28.2 °C

1.646

H2O: <0.1 g/100 mL at 22 ºC;45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.6 mg/mL

Store at RT

2.05X10-14 mm Hg at 25 deg C (est)

LD50 oral in mouse: 2gm/kg

Safety Information

III

6.1(b)

UN 2811 6.1/PG 3

3

46-61-21-25-62-22

53-22-26-36/37/39-45

TI4375000

T

Stable. Combustible. Incompatible with strong oxidizing agents.

P201-P280-P301 + P312 + P330-P308 + P313

H302-H360D

Thalidomide Use and Manufacturing

Thalidomide was prescribed as an anti-nausea agent to help pregnant women with morning sickness in the late 1950s. It was found to be a potent teratogen, causing many different forms of birth defects and was withdrawn from the market. Thalidomide and synthetic analogs have recently been proven effective in treating inflammation associated with diseases such as leprosy, arthritis and Crohn’s disease, and in cancers such as multiple myeloma. The direct target for the teratogenicity of thalidomide was not discovered until 2010, when it was found that it interacts directly with the protein cereblon (CRBN; IC50 = 8.5 nM), a ubiquitously-expressed E3 ligase. Binding of thalidomide analogs to CRBN-DNA damage binding protein-1 complexes account for the immunomodulatory and antiproliferative effects of these compounds.[Cayman Chemical]

Computed Properties

Molecular Weight:258.23
XLogP3:0.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:1
Exact Mass:258.06405680
Monoisotopic Mass:258.06405680
Topological Polar Surface Area:83.6
Heavy Atom Count:19
Complexity:449
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Unspecified

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • SHILPA PHARMA LIFESCIENCES LTD

    United States United States
    Active
  • LAURUS LABS LTD

    United States United States
    Active
  • HETERO LABS LTD

    United States United States
    Active

Recommended Suppliers of Thalidomide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.